Baseline susceptibility of primary HIV-2 to entry inhibitors.
BACKGROUND:
The baseline susceptibility of primary HIV-2 to maraviroc (MVC) and other entry inhibitors is currently unknown.
Read More
Resistance to antibody neutralization in HIV-2 infection occurs in late stage disease and is associated with X4 tropism.
OBJECTIVES:
To characterize the nature and dynamics of the neutralizing antibody (NAb) response and escape in chronically HIV-2 infected patients.
Read More
